W. Alberto Sifuentes Giraldo: Non-Criteria Manifestations of Antiphospholipid Syndrome
W. Alberto Sifuentes Giraldo, Rheumatologist at Hospital Nuestra Señora de Sonsoles (Sacyl), shared a post on X:
”Although the classification criteria for antiphospholipid syndrome (APS) classically require the presence of a thrombotic event in the venous vascular territory (e.g., deep vein thrombosis) or arterial territory (e.g., myocardial infarction, stroke), or recurrent fetal loss, this does not mean that patients with positive antiphospholipid antibodies who do not meet these criteria do not have this disorder.
The spectrum of APS manifestations is broad and encompasses several other symptoms that are not criteria, such as cutaneous manifestations including livedo reticularis, necrotic ulcers, pseudovasculitic lesions, digital gangrene, and splinter hemorrhages, among others.
The presence of antiphospholipid antibodies can also be associated with other symptoms, such as thrombocytopenia, valvular heart disease, epilepsy, or transverse myelitis. Furthermore, it carries an increased risk of other autoimmune disorders. In half of the cases, APS is associated with other autoimmune rheumatic diseases, the most frequent being systemic lupus erythematosus.
Non-Criteria Manifestations of Antiphospholipid Syndrome (APS). Adapted from: Pires da Rosa G, Espinosa G, Cervera R.
Non-criteria manifestations of antiphospholipid syndrome: an overview. Span J Med. 2021;1(2).”
Stay updated with Hemostasis Today.
-
Sep 18, 2026, 16:51Adarsh Krishnan Sundara Rajan: Is VTE the Most Underdiagnosed Critical Threat in Modern Healthcare?
-
Sep 18, 2026, 16:19CRISPR and Hemophilia: The Next Frontier of In Vivo Gene Editing
-
Sep 18, 2026, 16:13Christian Irsara: PF4 Immunothrombosis Following Natural Adenovirus Infection
-
Sep 18, 2026, 16:10Leo Nicolai։ The Spleen Emerges as a Key Regulator of Thromboinflammation
-
Sep 18, 2026, 16:05Targeting Factor XI to Reduce Thrombosis Without Compromising Hemostasis – ISTH
-
Sep 18, 2026, 15:54Swapnil Pawar: Why Aren’t We Using Cryopreserved Platelets Everywhere Yet?
-
Sep 18, 2026, 15:37Abdul Mannan: Evaluating Longitudinal Platelet Trends Beyond Standard Reference Intervals
-
Sep 18, 2026, 15:30Peter A. Everts։ Platelet Phenotype May Hold the Key to More Consistent PRP Therapy
-
Sep 18, 2026, 15:25Brandon Temple: Turning Personal Experience Into Advocacy for wAIHA Research